A Gocht Selected Research

4-1BB Ligand (4 1BB Ligand)

1/2014

Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Gocht Research Topics

Disease

1	Neoplasms (Cancer) 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Arteriovenous Fistula 12/2003
1	Pulmonary Hypertension 12/2003
1	Thrombocytosis (Thrombocythemia) 12/2003
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 12/2003
1	POEMS Syndrome (Syndrome, POEMS) 12/2003
1	Thrombosis (Thrombus) 06/2003
1	Septic Shock (Toxic Shock Syndrome) 06/2003
1	Hemorrhage 06/2003
1	Infections 10/2001
1	Virus Diseases (Viral Diseases) 10/2001
1	Melanoma (Melanoma, Malignant) 07/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2000

Drug/Important Bio-Agent (IBA)

1	4-1BB Ligand (4 1BB Ligand)IBA 01/2014
1	Bispecific AntibodiesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2003
1	DNA (Deoxyribonucleic Acid)IBA 10/2001
1	AntigensIBA 07/2000

Therapy/Procedure

2	Laparotomy 06/2003 - 06/2003
1	Mastectomy (Mammectomy) 02/2000